ibutilide has been researched along with almokalant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Abrahamsson, C; Amos, GJ; Carlsson, L; Duker, G; Hondeghem, L; Palmer, M | 1 |
2 other study(ies) available for ibutilide and almokalant
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.
Topics: Action Potentials; Alkanes; Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds; Calcium Channels, L-Type; Heart Ventricles; In Vitro Techniques; Inhibitory Concentration 50; Male; Models, Animal; Patch-Clamp Techniques; Perfusion; Potassium Channels; Propanolamines; Purkinje Fibers; Rabbits; Sulfonamides; Torsades de Pointes | 2001 |